RNAC

Generalized Myasthenia Gravis Market Outlook Shows Strong Momentum During the Forecast Period (2025–2034) Driven by Novel Immunotherapies | DelveInsight

01/14 02:00 pm

Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment

01/06 02:42 pm

AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate

07/24 01:08 pm

Cartesian Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

05/08 07:00 am

US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert

04/09 05:53 am

CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain

03/05 02:00 pm

By 2034, CAR-T Cell Therapy Market Set to Soar USD 8.7 Billion, at 1.80% CAGR: Prophecy Market Insights

08/27 08:49 am

Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates - Zacks Investment Research

07/03 02:30 pm

Cartesian Therapeutics Announces First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus

07/02 06:31 am

Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing

07/02 06:31 am

Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis

07/02 06:30 am

Cartesian Therapeutics Announces New Employment Inducement Grant

06/06 07:05 am

Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08

05/23 12:12 pm

Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis

05/22 07:00 am

Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

05/13 04:30 pm

What Makes Cartesian Therapeutics, Inc. (RNAC) a New Buy Stock

05/13 12:00 pm

Wall Street Analysts Think Cartesian Therapeutics, Inc. (RNAC) Could Surge 141%: Read This Before Placing a Bet

05/13 09:55 am

Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

05/08 07:00 am

Wall Street Analysts Believe Cartesian Therapeutics, Inc. (RNAC) Could Rally 146.24%: Here's is How to Trade

04/25 09:55 am

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

04/16 02:17 pm

Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy

04/10 02:34 pm

Down -30.75% in 4 Weeks, Here's Why You Should You Buy the Dip in Cartesian Therapeutics, Inc. (RNAC)

04/08 09:35 am

Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split

03/28 04:05 pm

LivePerson And 2 Other Stocks Under $2 Insiders Are Buying

03/19 07:55 am

Cartesian Therapeutics, Inc. (RNAC) Loses -24.65% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

03/14 09:35 am

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

03/06 08:00 am

Cartesian Therapeutics Announces New Employment Inducement Grant

03/05 08:05 am

Cartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, Maryland

03/05 08:00 am

Cartesian Therapeutics Announces New Employment Inducement Grants

02/05 05:05 pm

Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity

01/08 08:10 am

Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia Gravis

01/08 08:00 am

Emergent Biosolutions (EBS) Reports Q3 Loss, Tops Revenue Estimates

12/11 11:05 am